These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 29486622

  • 1. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
    Belfiore A, Malaguarnera R, Nicolosi ML, Lappano R, Ragusa M, Morrione A, Vella V.
    Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
    [Abstract] [Full Text] [Related]

  • 2. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A.
    Oncotarget; 2016 Feb 16; 7(7):7683-700. PubMed ID: 26655502
    [Abstract] [Full Text] [Related]

  • 3. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V, Malaguarnera R, Nicolosi ML, Palladino C, Spoleti C, Massimino M, Vigneri P, Purrello M, Ragusa M, Morrione A, Belfiore A.
    Oncotarget; 2017 Jun 27; 8(26):43248-43270. PubMed ID: 28591735
    [Abstract] [Full Text] [Related]

  • 4. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.
    Vella V, Malaguarnera R, Nicolosi ML, Morrione A, Belfiore A.
    Biochim Biophys Acta Mol Cell Res; 2019 Nov 27; 1866(11):118522. PubMed ID: 31394114
    [Abstract] [Full Text] [Related]

  • 5. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
    Vella V, Giuliano M, Nicolosi ML, Majorana MG, Marć MA, Muoio MG, Morrione A, Maggiolini M, Lappano R, De Francesco EM, Belfiore A.
    Biomolecules; 2021 Jun 22; 11(7):. PubMed ID: 34206590
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer.
    Buraschi S, Morcavallo A, Neill T, Stefanello M, Palladino C, Xu SQ, Belfiore A, Iozzo RV, Morrione A.
    Matrix Biol Plus; 2020 May 22; 6-7():100022. PubMed ID: 33543020
    [Abstract] [Full Text] [Related]

  • 11. A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells.
    Chen Z, Liu J, Chu D, Shan Y, Ma G, Zhang H, Zhang XD, Wang P, Chen Q, Deng C, Chen W, Dimitrov DS, Zhao Q.
    Int J Biol Sci; 2018 May 22; 14(7):799-806. PubMed ID: 29910690
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.
    Lero MW, Shaw LM.
    Mol Cell Endocrinol; 2021 May 01; 527():111213. PubMed ID: 33607269
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM, Gierthy JF, Pentecost BT.
    J Steroid Biochem Mol Biol; 2008 Mar 01; 109(1-2):185-96. PubMed ID: 18337089
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Signaling by discoidin domain receptor 1 in cancer metastasis.
    Gadiya M, Chakraborty G.
    Cell Adh Migr; 2018 Mar 01; 12(4):315-323. PubMed ID: 30187813
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
    Sun X, Gupta K, Wu B, Zhang D, Yuan B, Zhang X, Chiang HC, Zhang C, Curiel TJ, Bendeck MP, Hursting S, Hu Y, Li R.
    J Biol Chem; 2018 Feb 23; 293(8):2841-2849. PubMed ID: 29298894
    [Abstract] [Full Text] [Related]

  • 20. The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast Cancer.
    Mathur T, Yee D.
    Endocrinology; 2021 Oct 01; 162(10):. PubMed ID: 34304271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.